Associate Professor Andrew Chang

Clinical Senior Lecturer
Clinical Ophthalmology &
Eye Health, Central Clinical School

Telephone +61 2 92324800
Fax +61 2 9221 1637

Map

Biographical details

Associate Professor Andrew Chang

MBBS (Hons), PhD (Syd), FRANZCO, FRACS,

Andrew Chang is a vitreoretinal ophthalmologist. He graduated from University of Sydney Medical School, underwent registrar training at the Sydney Eye Hospital and fellowship training at Royal Victorian Eye and Ear Hospital, Manhattan Eye Ear and Throat Hospital and the University of California Davis. He was awarded a PhD for research into retinal angiography.

Positions include Consultant Vitreoretinal Surgeon and Head of the Retinal Unit at the Sydney Eye Hospital,Clinical Associate Professor University of Sydney, medical director of Sydney Retina Clinic, Secretary General of the Asia-Pacific Vitreoretinal Society (APVRS) and NSW RANZCO Committee member serving on the Federal RANZCO Council.

Professional awards include the Achievement Award and Distinguished Service Award of the Asia Pacific Academy of Ophthalmology (APAO) and the RANZCO Excellence in Teaching Award.

Dr Chang is involved in clinical trials research and is the Section Editor of Clinical and Experimental Ophthalmology.

Research interests

Clinical ophthalmology and visual science.

Clinical trials.

Basic science retinal and choroidal surgery.

Teaching and supervision

MPhil supervision of visual sciences research

PhD supervision of visual sciences research

Undergraduate USyd Central Clinical School

Accredited trainees in Ophthalmology.

Retinal fellowship Sydney Eye Hospital

Current research students

Project title Research student
Clinical challenges of anti-VEGF therapy for the treatment of macular oedema. Kimberly SPOONER

Associations

APVRS: Secretary General

RANZCO: Federal Councillor

RACS: Fellow

Awards and honours

Achievement Award APAO

Distinguished Service Award APAO

Teaching Award RANZCO

Selected grants

2001

  • Investigation of indocyanine green dye with the interaction of retinal tissue; Chang A, Zhu M; Eye and Vision Research Institute/Research Grant.
  • Save Sight and Eye Health Institute; Chang A, Billson F, Zhu M; Sydney Eye Hospital Foundation/Research Project Support.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Spooner, K., Hong, T., Bahrami, B., Chang, A. (2019). A meta-analysis of patients with treatment-resistant macular oedema secondary to retinal vein occlusions following switching to aflibercept. Acta Ophthalmologica, 97(1), 15-23. [More Information]
  • Bahrami, B., Hong, T., Schlub, T., Chang, A. (2019). AFLIBERCEPT FOR PERSISTENT DIABETIC MACULAR EDEMA: Forty-Eight-Week Outcomes. Retina, 39(1), 61-68. [More Information]
  • Broadhead, G., Grigg, J., McCluskey, P., Hong, T., Schlub, T., Chang, A. (2019). Saffron therapy for the treatment of mild/moderate age-related macular degeneration: a randomised clinical trial. Graefe's Archive for Clinical and Experimental Ophthalmology, 257(1), 31-40. [More Information]
  • Chow, N., Hong, T., Chang, A. (2018). Multimodal imaging of macular subretinal deposits following intravitreal ocriplasmin injection. American Journal of Ophthalmology Case Reports, 9, 80-84. [More Information]
  • Spooner, K., Mhlanga, C., Hong, T., Broadhead, G., Chang, A. (2018). The burden of neovascular age-related macular degeneration: A patient's perspective. Clinical Ophthalmology, 12, 2483-2491. [More Information]
  • Bahrami, B., Hong, T., Gilles, M., Chang, A. (2017). Anti-VEGF Therapy for Diabetic Eye Diseases. Asia-Pacific Journal of Ophthalmology, 6(6), 535-545. [More Information]
  • Chew, J., Zhu, M., Broadhead, G., Luo, K., Hong, T., Chang, A. (2017). Bilateral Neovascular Age-Related Macular Degeneration: Comparisons between First and Second Eyes. Ophthalmologica, 238, 23-30. [More Information]
  • Nair, R., Chang, A. (2017). Challenges in the treatment of age-related macular degeneration. Medicine Today, 18(2), 44-47.
  • Broadhead, G., Hong, T., McCluskey, P., Grigg, J., Schlub, T., Chang, A. (2017). Choroidal Thickness and Microperimetry Sensitivity in Age-Related Macular Degeneration. Ophthalmic Research, 58(1), 27-34. [More Information]
  • Bahrami, B., Ewe, S., Hong, T., Zhu, M., Ong, G., Luo, K., Chang, A. (2017). Influence of retinal pathology on the reliability of macular thickness measurement: A comparison between optical coherence tomography devices. Ophthalmic Surgery, Lasers and Imaging Retina, 48(4), 319-325. [More Information]
  • Bahrami, B., Hong, T., Chang, A. (2017). Re: Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema. Graefe's Archive for Clinical and Experimental Ophthalmology, 255(7), 1453-1454. [More Information]
  • Bahrami, B., Hong, T., Zhu, M., Schlub, T., Chang, A. (2017). Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema. Graefe's Archive for Clinical and Experimental Ophthalmology, 255, 1133-1140. [More Information]
  • Spooner, K., Hong, T., Wijeyakumar, W., Chang, A. (2017). Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: A systematic review with meta-analysis. Clinical Ophthalmology, 11, 161-177. [More Information]
  • Zhu, M., Wijeyakumar, W., Syed, A., Joachim, N., Hong, T., Broadhead, G., Li, H., Luo, K., Chang, A. (2017). Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration. Graefe's Archive for Clinical and Experimental Ophthalmology, 255(3), 475-484. [More Information]
  • Broadhead, G., Grigg, J., McCluskey, P., Korsakova, M., Chang, A. (2016). Bevacizumab for choroidal neovascularisation in enhanced S-cone syndrome. Documenta Ophthalmologica, 133(2), 139-143. [More Information]
  • Bahrami, B., Zhu, M., Hong, T., Chang, A. (2016). Diabetic macular oedema: pathophysiology, management challenges and treatment resistance. Diabetologia, 59(8), 1594-1608. [More Information]
  • Broadhead, G., Chang, A., Grigg, J., McCluskey, P. (2016). Efficacy and Safety of Saffron Supplementation: Current Clinical Findings. Critical Reviews in Food Science and Nutrition, 56(16), 2767-2776. [More Information]
  • Powner, M., Sim, D., Zhu, M., Nobre Cardoso, J., Jones, R., Syed, A., Chang, A., Keane, P., Tufail, A., Egan, C., et al (2016). Evaluation of nonperfused retinal vessels in ischemic retinopathy. Investigative Ophthalmology and Visual Science, 57(11), 5031-5037. [More Information]
  • Chang, A., Broadhead, G., Hong, T., Joachim, N., Syed, A., Schlub, T., Toth, L., Peto, T., Zhu, M. (2016). Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy Outcomes. Ophthalmic Research, 55(2), 84-90. [More Information]
  • Staffieri, S., Rose, L., Chang, A., De Roach, J., McLaren, T., Mackey, D., Hewitt, A., Lamey, T. (2015). Clinical and molecular characterization of females affected by X-linked retinoschisis. Clinical and Experimental Ophthalmology, 43(7), 643-647. [More Information]
  • Broadhead, G., Grigg, J., Chang, A., McCluskey, P. (2015). Dietary modification and supplementation for the treatment of age-related macular degeneration. Nutrition Reviews, 73(7), 448-462. [More Information]
  • Broadhead, G., Chang, A. (2015). Intravitreal aflibercept for choroidal neovascularisation complicating chronic central serous chorioretinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology, 253(6), 979-981. [More Information]
  • Zhu, M., Chew, J., Broadhead, G., Luo, K., Joachim, N., Hong, T., Syed, A., Chang, A. (2015). Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes. Graefe's Archive for Clinical and Experimental Ophthalmology, 253(8), 1217-1225. [More Information]
  • Broadhead, G., Hong, T., Zhu, M., Li, H., Schlub, T., Wijeyakumar, W., Chang, A. (2015). Response of pigment epithelial detachments to intravitreal aflibercept among patients with treatment-resistant neovascular age-related macular degeneration. Retina: the Journal of Retinal and Vitreous Diseases, 35(5), 975-981. [More Information]
  • Chang, A., Li, H., Broadhead, G., Luo, K., Zhu, M. (2015). Safety and Efficacy of Intravitreal Preservative-Free Triamcinolone Acetonide (Triesence) for Macular Edema. Journal of Ocular Pharmacology and Therapeutics, 31(9), 563-569. [More Information]
  • Chang, A., Hong, T., Ewe, Y., Bahrami, B., Broadhead, G. (2015). The role of aflibercept in the management of diabetic macular edema. Drug Design, Development and Therapy, 9, 4389-4396. [More Information]
  • Broadhead, G., Chang, A. (2014). Acetazolamide for cystoid macular oedema in Bietti crystalline retinal dystrophy. Korean Journal of Ophthalmology, 28(2), 189-191. [More Information]
  • Chang, A., Li, H., Broadhead, G., Hong, T., Schlub, T., Wijeyakumar, W., Zhu, M. (2014). Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration. Ophthalmology, 121(1), 188-192. [More Information]
  • Broadhead, G., Hong, T., Chang, A. (2014). Treating the untreatable patient: Current options for the management of treatment-resistant neovascular age-related macular degeneration. Acta Ophthalmologica, 92(8), 713-723. [More Information]
  • Broadhead, G., Chang, A. (2013). Choroidal neovascularization in acquired partial lipodystrophy. European Journal of Ophthalmology, 23(3), 439-441. [More Information]
  • Wang, Y., Chang, A. (2013). Clinical features and PDT effect of patients with CCSC. Guoji Yanke Zazhi (International Eye Science), 13(3), 522-526. [More Information]
  • Chui, J., Herkes, G., Chang, A. (2013). Management of fingolimod-associated macular edema. JAMA Ophthalmology, 131(5), 694-696. [More Information]
  • Simunovic, M., Rush, R., Hunyor, A., Chang, A. (2012). Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. British Journal of Ophthalmology, 96(6), 862-866. [More Information]
  • Merani, R., Hunyor, A., Playfair, T., Chang, A., Gregory-Roberts, J., Hunyor, A., Azar, D., Cumming, R. (2007). Pars Plana Vitrectomy for the Management of Retained Lens Material After Cataract Surgery. American Journal of Ophthalmology, 144(3), 364-370. [More Information]
  • Chong, C., Chang, A. (2006). Traumatic optic nerve avulsion and central retinal artery occlusion following rugby injury. Clinical and Experimental Ophthalmology, 34(1), 88-89.
  • Jiang, W., Zhong, Z., Henson, J., Neumann, A., Chang, A., Reddel, R. (2005). Suppression of Alternative Lengthening of Telomeres by Sp100-Mediated Sequestration of the MRE11/RAD50/NBS1 Complex. Molecular and Cellular Biology, 25(7), 2708-2721. [More Information]
  • Chang, A., Zhu, M., Billson, F. (2005). The Interaction of Indocyanine Green with Human Retinal Pigment Epithelium. Investigative Ophthalmology and Visual Science, 46(4), 1463-1467. [More Information]
  • Chang, A., Cha, J., Koentgen, F., Reddel, R. (2005). The murine stanniocalcin 1 gene is not essential for growth and development. Molecular and Cellular Biology, 25(23), 10604-10610. [More Information]
  • Wong, J., Sachdev, N., Beaumont, P., Chang, A. (2005). Visual outcomes following vitrectomy and peeling of epiretinal membrane. Clinical and Experimental Ophthalmology, 33(4), 373-378. [More Information]
  • Sirimaharaj, M., Balachandran, C., Chan, W., Hunyor, A., Chang, A., Gregory-Roberts, J., Hunyor, A., Playfair, T. (2005). Vitrectomy with short term postoperative tamponade using perfluorocarbon liquid for giant retinal tears. British Journal of Ophthalmology, 89(9), 1176-1179. [More Information]
  • Chang, A., Raik, E., Marsden, K., Ma, D. (2004). Australasian CD34+ Quality Assurance Program And Rationale For The Clinical Utility Of The Single-Platform Method For CD34+ Cell Enumeration. Cytotherapy, 6(1), 50-61. [More Information]
  • Chang, A., Zhu, M., Billson, F., Kumar, N., Beaumont, P. (2004). Indocyanine green localisation in surgically excised choroidal neovascular membrane in age-related macular degeneration. British Journal of Ophthalmology, 88(2), 307-309. [More Information]
  • Chang, A., Guyer, D., Orlock, D., Yannuzzi, L. (2003). Age-dependent variations in the drusen fluorescence on indocyanine green angiography. Clinical and Experimental Ophthalmology, 31(4), 300-304. [More Information]
  • Chang, A., Jellinek, D., Reddel, R. (2003). Mammalian stanniocalcins and cancer. Endocrine-Related Cancer, 10(3), 359-373. [More Information]

2019

  • Spooner, K., Hong, T., Bahrami, B., Chang, A. (2019). A meta-analysis of patients with treatment-resistant macular oedema secondary to retinal vein occlusions following switching to aflibercept. Acta Ophthalmologica, 97(1), 15-23. [More Information]
  • Bahrami, B., Hong, T., Schlub, T., Chang, A. (2019). AFLIBERCEPT FOR PERSISTENT DIABETIC MACULAR EDEMA: Forty-Eight-Week Outcomes. Retina, 39(1), 61-68. [More Information]
  • Broadhead, G., Grigg, J., McCluskey, P., Hong, T., Schlub, T., Chang, A. (2019). Saffron therapy for the treatment of mild/moderate age-related macular degeneration: a randomised clinical trial. Graefe's Archive for Clinical and Experimental Ophthalmology, 257(1), 31-40. [More Information]

2018

  • Chow, N., Hong, T., Chang, A. (2018). Multimodal imaging of macular subretinal deposits following intravitreal ocriplasmin injection. American Journal of Ophthalmology Case Reports, 9, 80-84. [More Information]
  • Spooner, K., Mhlanga, C., Hong, T., Broadhead, G., Chang, A. (2018). The burden of neovascular age-related macular degeneration: A patient's perspective. Clinical Ophthalmology, 12, 2483-2491. [More Information]

2017

  • Bahrami, B., Hong, T., Gilles, M., Chang, A. (2017). Anti-VEGF Therapy for Diabetic Eye Diseases. Asia-Pacific Journal of Ophthalmology, 6(6), 535-545. [More Information]
  • Chew, J., Zhu, M., Broadhead, G., Luo, K., Hong, T., Chang, A. (2017). Bilateral Neovascular Age-Related Macular Degeneration: Comparisons between First and Second Eyes. Ophthalmologica, 238, 23-30. [More Information]
  • Nair, R., Chang, A. (2017). Challenges in the treatment of age-related macular degeneration. Medicine Today, 18(2), 44-47.
  • Broadhead, G., Hong, T., McCluskey, P., Grigg, J., Schlub, T., Chang, A. (2017). Choroidal Thickness and Microperimetry Sensitivity in Age-Related Macular Degeneration. Ophthalmic Research, 58(1), 27-34. [More Information]
  • Bahrami, B., Ewe, S., Hong, T., Zhu, M., Ong, G., Luo, K., Chang, A. (2017). Influence of retinal pathology on the reliability of macular thickness measurement: A comparison between optical coherence tomography devices. Ophthalmic Surgery, Lasers and Imaging Retina, 48(4), 319-325. [More Information]
  • Bahrami, B., Hong, T., Chang, A. (2017). Re: Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema. Graefe's Archive for Clinical and Experimental Ophthalmology, 255(7), 1453-1454. [More Information]
  • Bahrami, B., Hong, T., Zhu, M., Schlub, T., Chang, A. (2017). Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema. Graefe's Archive for Clinical and Experimental Ophthalmology, 255, 1133-1140. [More Information]
  • Spooner, K., Hong, T., Wijeyakumar, W., Chang, A. (2017). Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: A systematic review with meta-analysis. Clinical Ophthalmology, 11, 161-177. [More Information]
  • Zhu, M., Wijeyakumar, W., Syed, A., Joachim, N., Hong, T., Broadhead, G., Li, H., Luo, K., Chang, A. (2017). Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration. Graefe's Archive for Clinical and Experimental Ophthalmology, 255(3), 475-484. [More Information]

2016

  • Broadhead, G., Grigg, J., McCluskey, P., Korsakova, M., Chang, A. (2016). Bevacizumab for choroidal neovascularisation in enhanced S-cone syndrome. Documenta Ophthalmologica, 133(2), 139-143. [More Information]
  • Bahrami, B., Zhu, M., Hong, T., Chang, A. (2016). Diabetic macular oedema: pathophysiology, management challenges and treatment resistance. Diabetologia, 59(8), 1594-1608. [More Information]
  • Broadhead, G., Chang, A., Grigg, J., McCluskey, P. (2016). Efficacy and Safety of Saffron Supplementation: Current Clinical Findings. Critical Reviews in Food Science and Nutrition, 56(16), 2767-2776. [More Information]
  • Powner, M., Sim, D., Zhu, M., Nobre Cardoso, J., Jones, R., Syed, A., Chang, A., Keane, P., Tufail, A., Egan, C., et al (2016). Evaluation of nonperfused retinal vessels in ischemic retinopathy. Investigative Ophthalmology and Visual Science, 57(11), 5031-5037. [More Information]
  • Chang, A., Broadhead, G., Hong, T., Joachim, N., Syed, A., Schlub, T., Toth, L., Peto, T., Zhu, M. (2016). Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy Outcomes. Ophthalmic Research, 55(2), 84-90. [More Information]

2015

  • Staffieri, S., Rose, L., Chang, A., De Roach, J., McLaren, T., Mackey, D., Hewitt, A., Lamey, T. (2015). Clinical and molecular characterization of females affected by X-linked retinoschisis. Clinical and Experimental Ophthalmology, 43(7), 643-647. [More Information]
  • Broadhead, G., Grigg, J., Chang, A., McCluskey, P. (2015). Dietary modification and supplementation for the treatment of age-related macular degeneration. Nutrition Reviews, 73(7), 448-462. [More Information]
  • Broadhead, G., Chang, A. (2015). Intravitreal aflibercept for choroidal neovascularisation complicating chronic central serous chorioretinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology, 253(6), 979-981. [More Information]
  • Zhu, M., Chew, J., Broadhead, G., Luo, K., Joachim, N., Hong, T., Syed, A., Chang, A. (2015). Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes. Graefe's Archive for Clinical and Experimental Ophthalmology, 253(8), 1217-1225. [More Information]
  • Broadhead, G., Hong, T., Zhu, M., Li, H., Schlub, T., Wijeyakumar, W., Chang, A. (2015). Response of pigment epithelial detachments to intravitreal aflibercept among patients with treatment-resistant neovascular age-related macular degeneration. Retina: the Journal of Retinal and Vitreous Diseases, 35(5), 975-981. [More Information]
  • Chang, A., Li, H., Broadhead, G., Luo, K., Zhu, M. (2015). Safety and Efficacy of Intravitreal Preservative-Free Triamcinolone Acetonide (Triesence) for Macular Edema. Journal of Ocular Pharmacology and Therapeutics, 31(9), 563-569. [More Information]
  • Chang, A., Hong, T., Ewe, Y., Bahrami, B., Broadhead, G. (2015). The role of aflibercept in the management of diabetic macular edema. Drug Design, Development and Therapy, 9, 4389-4396. [More Information]

2014

  • Broadhead, G., Chang, A. (2014). Acetazolamide for cystoid macular oedema in Bietti crystalline retinal dystrophy. Korean Journal of Ophthalmology, 28(2), 189-191. [More Information]
  • Chang, A., Li, H., Broadhead, G., Hong, T., Schlub, T., Wijeyakumar, W., Zhu, M. (2014). Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration. Ophthalmology, 121(1), 188-192. [More Information]
  • Broadhead, G., Hong, T., Chang, A. (2014). Treating the untreatable patient: Current options for the management of treatment-resistant neovascular age-related macular degeneration. Acta Ophthalmologica, 92(8), 713-723. [More Information]

2013

  • Broadhead, G., Chang, A. (2013). Choroidal neovascularization in acquired partial lipodystrophy. European Journal of Ophthalmology, 23(3), 439-441. [More Information]
  • Wang, Y., Chang, A. (2013). Clinical features and PDT effect of patients with CCSC. Guoji Yanke Zazhi (International Eye Science), 13(3), 522-526. [More Information]
  • Chui, J., Herkes, G., Chang, A. (2013). Management of fingolimod-associated macular edema. JAMA Ophthalmology, 131(5), 694-696. [More Information]

2012

  • Simunovic, M., Rush, R., Hunyor, A., Chang, A. (2012). Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. British Journal of Ophthalmology, 96(6), 862-866. [More Information]

2007

  • Merani, R., Hunyor, A., Playfair, T., Chang, A., Gregory-Roberts, J., Hunyor, A., Azar, D., Cumming, R. (2007). Pars Plana Vitrectomy for the Management of Retained Lens Material After Cataract Surgery. American Journal of Ophthalmology, 144(3), 364-370. [More Information]

2006

  • Chong, C., Chang, A. (2006). Traumatic optic nerve avulsion and central retinal artery occlusion following rugby injury. Clinical and Experimental Ophthalmology, 34(1), 88-89.

2005

  • Jiang, W., Zhong, Z., Henson, J., Neumann, A., Chang, A., Reddel, R. (2005). Suppression of Alternative Lengthening of Telomeres by Sp100-Mediated Sequestration of the MRE11/RAD50/NBS1 Complex. Molecular and Cellular Biology, 25(7), 2708-2721. [More Information]
  • Chang, A., Zhu, M., Billson, F. (2005). The Interaction of Indocyanine Green with Human Retinal Pigment Epithelium. Investigative Ophthalmology and Visual Science, 46(4), 1463-1467. [More Information]
  • Chang, A., Cha, J., Koentgen, F., Reddel, R. (2005). The murine stanniocalcin 1 gene is not essential for growth and development. Molecular and Cellular Biology, 25(23), 10604-10610. [More Information]
  • Wong, J., Sachdev, N., Beaumont, P., Chang, A. (2005). Visual outcomes following vitrectomy and peeling of epiretinal membrane. Clinical and Experimental Ophthalmology, 33(4), 373-378. [More Information]
  • Sirimaharaj, M., Balachandran, C., Chan, W., Hunyor, A., Chang, A., Gregory-Roberts, J., Hunyor, A., Playfair, T. (2005). Vitrectomy with short term postoperative tamponade using perfluorocarbon liquid for giant retinal tears. British Journal of Ophthalmology, 89(9), 1176-1179. [More Information]

2004

  • Chang, A., Raik, E., Marsden, K., Ma, D. (2004). Australasian CD34+ Quality Assurance Program And Rationale For The Clinical Utility Of The Single-Platform Method For CD34+ Cell Enumeration. Cytotherapy, 6(1), 50-61. [More Information]
  • Chang, A., Zhu, M., Billson, F., Kumar, N., Beaumont, P. (2004). Indocyanine green localisation in surgically excised choroidal neovascular membrane in age-related macular degeneration. British Journal of Ophthalmology, 88(2), 307-309. [More Information]

2003

  • Chang, A., Guyer, D., Orlock, D., Yannuzzi, L. (2003). Age-dependent variations in the drusen fluorescence on indocyanine green angiography. Clinical and Experimental Ophthalmology, 31(4), 300-304. [More Information]
  • Chang, A., Jellinek, D., Reddel, R. (2003). Mammalian stanniocalcins and cancer. Endocrine-Related Cancer, 10(3), 359-373. [More Information]

To update your profile click here. For support on your academic profile contact .